3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Withdrawn
1
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Non-Muscle Invasive Bladder Neoplasms
1
Interventions
Propofol
9
Sevoflurane
7
Rituximab
7
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Trastuzumab
5
Specimen Handling
5
Enoxaparin
5
Carboplatin
5
Bevacizumab
5
Nivolumab
4
Capecitabine
4
Bupivacaine
4
trametinib
3
pirtobrutinib
3
dabrafenib
3
atezolizumab
3
apixaban
3
Lenalidomide
3
Indocyanine Green
3
Gemcitabine
3
Docetaxel
3
Cyclophosphamide
3
zanubrutinib
2
venetoclax
2
trastuzumab deruxtecan
2
ribociclib
2
polyethylene glycol 3350
2
pertuzumab
2
pembrolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
5-aminolevulinic acid hexyl ester
×
Clear all
NCT05962541
2025-12-31
CUT-less
University of Roma La Sapienza
Phase 4
Recruiting
327 enrolled